We are live on ! Find out more
JFG

Jefferies Financial Group Portfolio holdings

AUM $14.6B
1-Year Est. Return 40.95%
This Fund
S&P 500
This Quarter Est. Return
+12.69%
1 Year Est. Return
+40.95%
3 Year Est. Return
+104.32%
5 Year Est. Return
+50.55%
10 Year Est. Return
+495.11%
AUM
$10.8B
AUM Growth
-$4.51B
Cap. Flow
-$5.9B
Cap. Flow %
-54.51%
Top 10 Hldgs %
36.37%
Holding
2,157
New
513
Increased
320
Reduced
516
Closed
607

Top Buys

Rank Stock Value
1
V icon
Visa
V
+$126M
2
XBI icon
State Street SPDR S&P Biotech ETF
XBI
+$56.9M
3
ARGX icon
argenx
ARGX
+$51.2M
4
DAL icon
Delta Air Lines
DAL
+$47.9M
5
GLNG icon
Golar LNG
GLNG
+$41.7M

Sector Composition

Rank Sector Weight
1 Healthcare 8.36%
2 Technology 4.71%
3 Industrials 4.28%
4 Financials 3.27%
5 Energy 3.16%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DNA icon
1276
Ginkgo Bioworks
DNA
$528M
$154K ﹤0.01%
+3,313
New +$171K
NOVA
1277
PUT
DELISTED
Sunnova Energy
NOVA
$153K ﹤0.01%
25,000
RGTI icon
1278
Rigetti Computing
RGTI
$4.94B
$153K ﹤0.01%
+100,000
New +$144K
PGY icon
1279
Pagaya Technologies
PGY
$1.47B
$152K ﹤0.01%
+15,000
New +$213K
APLT
1280
DELISTED
Applied Therapeutics
APLT
$151K ﹤0.01%
+22,200
New +$99.7K
SOL
1281
DELISTED
Emeren Group
SOL
$149K ﹤0.01%
+77,000
New +$157K
MEOH icon
1282
CALL
Methanex
MEOH
$4.27B
$147K ﹤0.01%
3,300
-46,700
-93% -$2.08M
FSP
1283
Franklin Street Properties
FSP
$48.1M
$146K ﹤0.01%
64,100
-100
-0.2% -$238
SACH
1284
Sachem Capital Corp
SACH
$38.6M
$145K ﹤0.01%
32,500
NPCE icon
1285
Neuropace
NPCE
$469M
$144K ﹤0.01%
+10,900
New +$155K
INSM icon
1286
CALL
Insmed
INSM
$22B
$144K ﹤0.01%
5,300
+2,200
+71% +$61.6K
KOPN icon
1287
Kopin
KOPN
$663M
$144K ﹤0.01%
+79,800
New +$177K
TSHA icon
1288
Taysha Gene Therapies
TSHA
$1.69B
$138K ﹤0.01%
+48,100
New +$100K
TTE icon
1289
TotalEnergies
TTE
$193B
$138K ﹤0.01%
+2,000
New +$131K
OUST icon
1290
Ouster
OUST
$2.39B
$137K ﹤0.01%
17,200
+7,200
+72% +$41K
PVBC
1291
DELISTED
Provident Bancorp
PVBC
$137K ﹤0.01%
15,000
+3,600
+32% +$36.1K
REXR icon
1292
Rexford Industrial Realty
REXR
$8.56B
$136K ﹤0.01%
+2,699
New +$143K
HRTG icon
1293
Heritage Insurance Holdings
HRTG
$907M
$135K ﹤0.01%
+12,700
New +$89.5K
LITE icon
1294
Lumentum
LITE
$53.9B
$135K ﹤0.01%
2,843
+1,262
+80% +$64.2K
KVUE icon
1295
Kenvue
KVUE
$37.1B
$131K ﹤0.01%
6,127
+49
+0.8% +$995
STXS icon
1296
Stereotaxis
STXS
$133M
$131K ﹤0.01%
+50,000
New +$119K
NOTV
1297
DELISTED
Inotiv
NOTV
$130K ﹤0.01%
+11,900
New +$71.1K
ADBE icon
1298
Adobe
ADBE
$98.5B
$129K ﹤0.01%
256
-5,727
-96% -$3.28M
ABSI icon
1299
Absci
ABSI
$1.29B
$128K ﹤0.01%
+22,600
New +$102K
INVE icon
1300
Identive
INVE
$64.8M
$128K ﹤0.01%
16,100
-400
-2% -$3.19K

Similar funds

Jefferies Financial Group's Q1 2024 Portfolio in Review

As of Q1 2024, Jefferies Financial Group held 2,157 positions worth $10.8B, down 29% from $15.3B the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Jefferies Financial Group withdrew a net $5.9B in Q1 2024, closing 607 positions and reducing 516 holdings. Its most notable exit was Surgery Partners, an estimated $146M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 8.4% of assets, up from 6.3% a quarter earlier, followed by Technology and Industrials.

Against the trend, Jefferies Financial Group opened a new position in Golar LNG worth $45M.

  • Jefferies Financial Group's largest Q1 2024 buy was Golar LNG: 1,872,202 shares worth $45M.
  • Jefferies Financial Group added most to Visa in Q1 2024, an estimated $126M increase.
  • Jefferies Financial Group's biggest Q1 2024 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $962M.
  • Jefferies Financial Group fully exited Surgery Partners in Q1 2024, selling an estimated $146M.
  • Jefferies Financial Group's ten largest holdings make up 36% of its $10.8B portfolio in Q1 2024.
  • Jefferies Financial Group opened 513 new positions and closed 607 in Q1 2024.
  • Jefferies Financial Group's portfolio value fell 29% quarter-over-quarter to $10.8B.

Based on Jefferies Financial Group's 13F filing for Q1 2024, filed 13 May 2024.